Kamakura, Japan

Masaji Oono

This inventor holds 1 USPTO granted patent. Top assignee: Kowa Company Limited. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaji Oono: Innovator in Azetidine Compounds

Introduction

Masaji Oono is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of chemistry, particularly in the development of azetidine derivatives. His work has implications for various applications in pharmaceuticals and chemical synthesis.

Latest Patents

Masaji Oono holds a patent for a 3-Alkylidine azetidine compound and their production. This patent describes an azetidine derivative characterized by a specific formula, wherein R can be a hydrogen atom or a hydroxyl group. The other components, R.sub.a, R.sub.b, R.sub.c, R.sub.a ', R.sub.b ', and R.sub.c ', can be identical or different, each representing a lower alkyl group. This innovation showcases his expertise in organic chemistry and compound synthesis.

Career Highlights

Oono is associated with Kowa Company Limited, where he has been able to apply his innovative ideas in a corporate setting. His work at Kowa has allowed him to contribute to advancements in chemical products and processes. With a patent portfolio that includes 1 patent, he has established himself as a valuable asset in the field of chemical research.

Collaborations

Masaji Oono has collaborated with notable colleagues such as Yoshio Takahashi and Hamao Umezawa. These partnerships have likely enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

Masaji Oono's contributions to the field of azetidine compounds reflect his innovative spirit and dedication to advancing chemical science. His work continues to influence the industry and inspire future research endeavors.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…